Schonfeld Strategic Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
|
|||||
|
2025
Q1 | $2.62M | Buy |
|
|||||
|
2024
Q4 | $3.03M | Sell |
|
|||||
|
2024
Q3 | $4.2M | Sell |
|
|||||
|
2024
Q2 | $5.98M | Buy |
|
|||||
|
2024
Q1 | $4.52M | Sell |
|
|||||
|
2023
Q4 | $2.64M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.05M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $583K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $211K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $306K | Sell |
|
|||||
|
2021
Q1 | $743K | Sell |
|
|||||
|
2020
Q4 | $4.08M | Buy |
|
|||||
|
2020
Q3 | $1.73M | Buy |
|
|||||
|
2020
Q2 | $1.16M | Buy |
|
|||||
|
2020
Q1 | $236K | Buy |
|
|||||
|
2019
Q4 | $60K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $165K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $489K | Buy |
|